DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Pryma DA, Chin BB, Noto RB. et al.
Efficacy and Safety of High-Specific-Activity (131)I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma.
J NUCL MED 2019;
60: 623-630
DOI: 10.2967/jnumed.118.217463. (PMID: 30291194)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.